Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer.
Saved in:
| Title: | Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer. |
|---|---|
| Authors: | Ando F; Department of Cell Biology, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo, Japan.; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan., Kashiwada T; Department of Pulmonary Medicine and Oncology, Nippon Medical School, Tokyo, Japan., Kuroda S; Department of Cell Biology, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo, Japan., Fujii T; Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo, Japan., Takano R; Department of Cell Biology, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo, Japan.; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan., Miyabe Y; Department of Cell Biology, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo, Japan.; Department of Immunology and Parasitology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan., Kunugi S; Department of Analytic Human Pathology, Nippon Medical School, Tokyo, Japan., Sakatani T; Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo, Japan., Miyanaga A; Department of Pulmonary Medicine and Oncology, Nippon Medical School, Tokyo, Japan., Asatsuma-Okumura T; Department of Cell Biology, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo, Japan., Hashiguchi M; Department of Cell Biology, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo, Japan., Kanazawa Y; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan., Ohashi R; Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo, Japan., Yoshida H; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan., Seike M; Department of Pulmonary Medicine and Oncology, Nippon Medical School, Tokyo, Japan., Gemma A; Department of Pulmonary Medicine and Oncology, Nippon Medical School, Tokyo, Japan., Iwai Y; Department of Cell Biology, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo, Japan. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2024 May 07; Vol. 15, pp. 1384731. Date of Electronic Publication: 2024 May 07 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38774209 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ando+F%22">Ando F</searchLink>; Department of Cell Biology, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo, Japan.; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kashiwada+T%22">Kashiwada T</searchLink>; Department of Pulmonary Medicine and Oncology, Nippon Medical School, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kuroda+S%22">Kuroda S</searchLink>; Department of Cell Biology, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Fujii+T%22">Fujii T</searchLink>; Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Takano+R%22">Takano R</searchLink>; Department of Cell Biology, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo, Japan.; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Miyabe+Y%22">Miyabe Y</searchLink>; Department of Cell Biology, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo, Japan.; Department of Immunology and Parasitology, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Kunugi+S%22">Kunugi S</searchLink>; Department of Analytic Human Pathology, Nippon Medical School, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Sakatani+T%22">Sakatani T</searchLink>; Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Miyanaga+A%22">Miyanaga A</searchLink>; Department of Pulmonary Medicine and Oncology, Nippon Medical School, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Asatsuma-Okumura+T%22">Asatsuma-Okumura T</searchLink>; Department of Cell Biology, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hashiguchi+M%22">Hashiguchi M</searchLink>; Department of Cell Biology, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kanazawa+Y%22">Kanazawa Y</searchLink>; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ohashi+R%22">Ohashi R</searchLink>; Department of Integrated Diagnostic Pathology, Nippon Medical School, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Yoshida+H%22">Yoshida H</searchLink>; Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Seike+M%22">Seike M</searchLink>; Department of Pulmonary Medicine and Oncology, Nippon Medical School, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Gemma+A%22">Gemma A</searchLink>; Department of Pulmonary Medicine and Oncology, Nippon Medical School, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Iwai+Y%22">Iwai Y</searchLink>; Department of Cell Biology, Institute for Advanced Medical Sciences, Nippon Medical School, Tokyo, Japan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2024 May 07; Vol. 15, pp. 1384731. <i>Date of Electronic Publication: </i>2024 May 07 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38774209 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fphar.2024.1384731 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1384731 Titles: – TitleFull: Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ando F – PersonEntity: Name: NameFull: Kashiwada T – PersonEntity: Name: NameFull: Kuroda S – PersonEntity: Name: NameFull: Fujii T – PersonEntity: Name: NameFull: Takano R – PersonEntity: Name: NameFull: Miyabe Y – PersonEntity: Name: NameFull: Kunugi S – PersonEntity: Name: NameFull: Sakatani T – PersonEntity: Name: NameFull: Miyanaga A – PersonEntity: Name: NameFull: Asatsuma-Okumura T – PersonEntity: Name: NameFull: Hashiguchi M – PersonEntity: Name: NameFull: Kanazawa Y – PersonEntity: Name: NameFull: Ohashi R – PersonEntity: Name: NameFull: Yoshida H – PersonEntity: Name: NameFull: Seike M – PersonEntity: Name: NameFull: Gemma A – PersonEntity: Name: NameFull: Iwai Y IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 05 Text: 2024 May 07 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 1663-9812 Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in pharmacology Type: main |
| ResultId | 1 |
